Biogen Idec, Inc. (Massachusetts) Reports Second Quarter 2007 Results

July 24, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today reported its second quarter 2007 results.

Twitter
LinkedIn
Facebook
Email
Print

Earnings

Biogen